Coexistence of visceral fat accumulation and sleep-disordered breathing correlates with coronary artery disease

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 8, 2012, Pages 728-735

  Nakagawa, Yasuhiko ^a   Kishida, Ken ^a   Funahashi, Tohru ^a   Yanagi, Koji ^b   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaka Chuo Byoin   (Japan)

Author keywords

Adiponectin; Coronary artery disease; Sleep disordered breathing; Visceral fat accumulation

Indexed keywords

CD40 LIGAND;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY FAT DISTRIBUTION; CLINICAL FEATURE; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE MARKER; DYSLIPIDEMIA; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; OBESITY; SLEEP DISORDERED BREATHING;

EID: 84865749009     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.13227     Document Type: Article

References (27)

1. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): casecontrol study. Lancet, 2004; 364: 937-952
2. Matsuzawa Y, Nakamura T, Shimomura I, Kotani K: Visceral fat accumulation and cardiovascular disease. Obes Res, 1995; 3: 645S-647S
3. Després JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature, 2006; 444: 881-887
4. Reaven GM: Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med, 1993; 44: 121-131
5. Shinohara E, Kihara S, Yamashita S, Yamane M, Nishida M, Arai T, Kotani K, Nakamura T, Takemura K, Matsuzawa Y: Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med, 1997; 241: 11-18
6. Grunstein RR, Wilcox I, Yang TS, Gould Y, Hedner JA: Snoring and sleep apnea in men: interaction with central obesity and hypertension. Int J Obesity, 1993; 17: 553-540
7. Vgontzas AN, Bixler EO, Chrousos GP: Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J Intern Med, 2003; 254: 32-44
8. Wilcox I, McNamara SG, Collins FL, Grunstein RR, Sullivan CE: 'Syndrome Z': The Interaction of sleep apnoea, vascular risk factors and heart disease. Thorax, 1998; 53: S25-28
9. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, O'Connor GT, Boland LL, Schwartz JE, Samet JM: Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med, 2001; 163: 19-25
10. Lattimore JD, Celermajer DS, Wilcox I: Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol, 2003; 41: 1429-1437
11. Shamsuzzaman AS, Gersh BJ, Somers VK: Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA, 2003; 290: 1906-1914
12. Vgontzas AN, Bixler EO, Chrousos GP: Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J Intern Med, 2003; 254: 32-44
13. Marin JM, Carrizo SJ, Vicente E, Agusti AG: Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet, 2005; 365: 1046-1053
14. Wilcox I, Booth V, Lattimore J: Sleep apnea and heart disease. N Engl J Med, 2006; 354: 1086-1089
15. Punjabi NM, Newman AB, Young TB, Resnick HE, Sanders MH: Sleep-disordered breathing and cardiovascular disease: an outcome-based definition of hypopneas. Am J Respir Crit Care Med, 2008; 177: 1150-1155
16. Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, Takahashi M, Arita Y, Kihara S, Matsuzawa Y: Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med, 1999; 38: 202-206
17. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest, 2004; 114: 1752-1761
18. Nakagawa Y, Kishida K, Kihara S, Sonoda M, Hirata A, Yasui A, Nishizawa H, Nakamura T, Yoshida R, Shimomura I, Funahashi T: Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome. Am J Physiol Endocrinol Metab, 2008; 294: E778-784
19. Nakagawa Y, Kishida K, Kihara S, Yoshida R, Funahashi T, Shimomura I: Nocturnal falls of adiponectin levels in sleep apnea with abdominal obesity and impact of hypoxia-induced dysregulated adiponectin production in obese murine mesenteric adipose tissue. J Atheroscler Thromb, 2011; 18: 240-247
20. Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, Simoons ML; CAPTURE Study Investigators: Soluble CD40 ligand in acute coro nary syndromes. N Engl J Med, 2003; 348: 1104-1111
21. Anonymous: Sleep-Related Breathing Disorders in Adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep, 1999; 22: 667-689
22. Collop NA, Anderson WM, Boehlecke B, Claman D, Goldberg R, Gottlieb DJ, Hudgel D, Sateia M, Schwab R: Portable Monitoring Task Force of the American Academy of Sleep Medicine. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med, 200; 3: 737-747
23. Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, Daida H, Biro S, Hirobe K, Funahashi T, Yokote K, Yokode M: Metabolic syndrome. J Atheroscler Thromb, 2008; 15: 1-5
24. Pillar G, Shehadeh N: Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care, 2008; 31: S303-309
25. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB: Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet, 1997; 349: 462-466
26. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB: Elevated C-reactive protein levels in overweight and obese adults. JAMA, 1999; 282: 2131-2135
27. Ryan S, McNicholas WT: Intermittent hypoxia and activation of inflammatory molecular pathways in OSAS. Arch Physiol Biochem, 2008; 114: 261-266